Package 50090-5852-1

{"route": ["ORAL"], "spl_id": "083acc4f-83b4-42c8-8d6c-8786375d6c0f", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313565"], "spl_set_id": ["df34e11d-5f2c-4755-b84b-b95d1d7b73f0"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "10 TABLET, FILM COATED in 1 BOTTLE (50090-5852-0)", "package_ndc": "50090-5852-0", "marketing_start_date": "20211110"}, {"sample": false, "description": "14 TABLET, FILM COATED in 1 BOTTLE (50090-5852-1)", "package_ndc": "50090-5852-1", "marketing_start_date": "20211110"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (50090-5852-2)", "package_ndc": "50090-5852-2", "marketing_start_date": "20211110"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (50090-5852-3)", "package_ndc": "50090-5852-3", "marketing_start_date": "20211110"}], "brand_name": "Valacyclovir Hydrochloride", "product_id": "50090-5852_083acc4f-83b4-42c8-8d6c-8786375d6c0f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "50090-5852", "generic_name": "Valacyclovir Hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir Hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA090682", "marketing_category": "ANDA", "marketing_start_date": "20100524", "listing_expiration_date": "20261231"}